Promoted Content

Promoted Content

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Taiba Healthcare

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

OMAN Oman

Post An Enquiry

Virtual Innovation Day

Participation Not Confirmed

Update your events

Elevar Therapeutics and Taiba Middle East FZ LLC Partner to Commercialize Apealea® in the Middle East and North Africa Region

Contact the Supplier

Lead Product(s): Paclitaxel,Carboplatin

Therapeutic Area: Oncology Product Name: Apealea

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Elevar Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement October 05, 2020

Details:

Tiba will be responsible for managing named-patient requests through which physicians can legally and ethically prescribe Apealea for patients prior to commercial availability, commercialize and distribute the product throughout the Middle East and North African region.